RSV/Influenza A+B Combo Rapid Test (UDI 06976202762838)
Manufactured by Zhejiang Greylynx Biotech Co., Ltd.
Device Regulatory Overview
The RSV/Influenza A+B Combo Rapid Test (Model/Catalog Number: GIRF-732) is a medical device manufactured by Zhejiang Greylynx Biotech Co., Ltd.. This product is indexed under FDA Product Code / Category Classification W0105070599 within international Unique Device Identification (UDI) compliance databases.
Technical Specifications
- Model Number
- GIRF-732
- Product Code / EMDN
- W0105070599
- Device Name
- RSV/Influenza A+B Combo Rapid Test
- Database Sync Date
- 2026-08-09 16:28:46
Full Regulatory Attributes
🔒 Token Gated
{
"review_panel": "AN",
"gudid_di_status": "Published",
"sterilization_methods": ["EO", "Gamma"],
"rx_only": true
}
Unlock Compliance Data & Serialization Specs
Access raw JSON payloads, UDI-DI packaging hierarchies, and Notified Body IDs.
Get API Token Access ($49/mo)Frequently Asked Questions
Who is the primary manufacturer of RSV/Influenza A+B Combo Rapid Test?
The registered manufacturer of record for RSV/Influenza A+B Combo Rapid Test is Zhejiang Greylynx Biotech Co., Ltd..
What is the Primary UDI-DI identifier for RSV/Influenza A+B Combo Rapid Test?
The Primary UDI-DI identifier registered in FDA GUDID and EUDAMED records is 06976202762838.
What classification code is assigned to this device?
This device is registered under product classification code W0105070599.
Similar Classification Devices (W0105070599)
Other Devices by Zhejiang Greylynx Biotech Co., Ltd.
Programmatic Export
Export this master device record as standardized JSON or CSV for compliance audits.
JSON API Endpoint